Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors

The drugs currently used to treat leishmaniases have limitations concerning cost, efficacy, and safety, making the search for new therapeutic approaches urgent. We found that the gold­(I)-derived complexes were active against L. infantum and L. braziliensis intracellular amastigotes with IC50 values...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS infectious diseases 2020-05, Vol.6 (5), p.1121-1139
Hauptverfasser:	Tunes, Luiza G, Morato, Roberta E, Garcia, Adriana, Schmitz, Vinicius, Steindel, Mario, Corrêa-Junior, José D, Dos Santos, Hélio F, Frézard, Frédéric, de Almeida, Mauro V, Silva, Heveline, Moretti, Nilmar S, de Barros, André L. B, do Monte-Neto, Rubens L
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!